Hoth Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Hoth Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Hoth Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $15.3M, a 19.5% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $15.3M +$2.5M +19.5% Dec 31, 2023 10-K 2024-03-28
Q4 2022 $12.8M +$4.53M +54.7% Dec 31, 2022 10-K 2024-03-28
Q4 2021 $8.28M +$4.26M +106% Dec 31, 2021 10-K 2023-03-31
Q4 2020 $4.03M +$1.49M +58.7% Dec 31, 2020 10-K 2022-03-30
Q4 2019 $2.54M +$1.69M +201% Dec 31, 2019 10-K 2021-03-16
Q4 2018 $843K +$418K +98.2% Dec 31, 2018 10-K 2020-03-02
Q4 2017 $425K Dec 31, 2017 10-K 2019-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.